KINASE INHIBITOR SALTS AND COMPOSITIONS THEREOF
The present invention relates methods for treating thyroid cancer, renal cell carcinoma or hepatocellar carcinoma comprising orally administering to a patient in need of such therapy a therapeutic amount of cabozantinib lauryl sulfate salt, preferably in a capsule form. The method allows the administration of the therapeutic amount of cabozantinib lauryl sulfate salt in a fed state or a fasted state and the administration does not exhibit a food effect.
1 . Cabozantinib lauryl sulfate salt.
2 . An oral dosage from comprising a therapeutic amount of the salt of claim 1 and one or more excipients.
3 . The oral dosage form of claim 2 wherein the dosage form is a capsule.
4 . The oral dosage form of claim 2 wherein the dosage form is a tablet.